These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 9595452

  • 1. Structure-activity analysis of C-terminal endothelin analogues.
    Rovero P, Galoppini C, Laricchia-Robbio L, Mazzoni MR, Revoltella RP.
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S251-4. PubMed ID: 9595452
    [Abstract] [Full Text] [Related]

  • 2. A structure-activity study of a C-terminal endothelin analogue.
    Cassano E, Galoppini C, Giusti L, Hamdan M, Macchia M, Mazzoni MR, Menchini E, Pegoraro S, Rovero P.
    Folia Biol (Praha); 1998; 44(1):11-4. PubMed ID: 10730869
    [Abstract] [Full Text] [Related]

  • 3. Toward the rational development of peptidomimetic analogs of the C-terminal endothelin hexapeptide: development of a theoretical model.
    Macchia M, Barontini S, Ceccarelli F, Galoppini C, Giusti L, Hamdan M, Lucacchini A, Martinelli A, Menchini E, Mazzoni MR, Revoltella RP, Romagnoli F, Rovero P.
    Farmaco; 1998; 53(8-9):545-56. PubMed ID: 10081817
    [Abstract] [Full Text] [Related]

  • 4. Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.
    Cody WL, He JX, DePue PL, Waite LA, Leonard DM, Sefler AM, Kaltenbronn JS, Haleen SJ, Walker DM, Flynn MA.
    J Med Chem; 1995 Jul 21; 38(15):2809-19. PubMed ID: 7636842
    [Abstract] [Full Text] [Related]

  • 5. Receptor binding and biologic activity of synthetic ET-1 peptides in the retinal pericyte.
    McDonald DM, Bailie JR, Archer DB, Chakravarthy U.
    Invest Ophthalmol Vis Sci; 1996 May 21; 37(6):1067-73. PubMed ID: 8631622
    [Abstract] [Full Text] [Related]

  • 6. Detection and epitope mapping of immunoreactive human endothelin-1 using ELISA and a surface plasmon resonance-based biosensor.
    Laricchia-Robbio L, Moscato S, Guidi A, Viganò S, Rovero P, Revoltella RP.
    Biosens Bioelectron; 1997 May 21; 12(8):765-78. PubMed ID: 9421886
    [Abstract] [Full Text] [Related]

  • 7. Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.
    Cody WL, He JX, Reily MD, Haleen SJ, Walker DM, Reyner EL, Stewart BH, Doherty AM.
    J Med Chem; 1997 Jul 04; 40(14):2228-40. PubMed ID: 9216842
    [Abstract] [Full Text] [Related]

  • 8. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors.
    Rose PM, Krystek SR, Patel PS, Liu EC, Lynch JS, Lach DA, Fisher SM, Webb ML.
    FEBS Lett; 1995 Mar 20; 361(2-3):243-9. PubMed ID: 7698331
    [Abstract] [Full Text] [Related]

  • 9. A rabbit antiserum raised against the hexapeptide endothelin(16-21) shows different binding affinities for endothelin-1, -2 and -3.
    Löffler BM, Jacot-Guillarmod H.
    Life Sci; 1992 Mar 20; 50(25):2001-9. PubMed ID: 1593928
    [Abstract] [Full Text] [Related]

  • 10. Structure-activity relationship for ETB agonism in truncated endothelin-1 analogs.
    Saeki T, Ihara M, Fukuroda T, Yano M.
    Biochem Int; 1992 Oct 20; 28(2):305-12. PubMed ID: 1456952
    [Abstract] [Full Text] [Related]

  • 11. Truncated analogues of endothelin and sarafotoxin are selective for the ETB receptor subtype.
    Heyl DL, Cody WL, He JX, Flynn MA, Welch KM, Reynolds EE, Doherty AM.
    Pept Res; 1993 Oct 20; 6(5):238-41. PubMed ID: 8257799
    [Abstract] [Full Text] [Related]

  • 12. Alanine scan of endothelin: importance of aromatic residues.
    Tam JP, Liu W, Zhang JW, Galantino M, Bertolero F, Cristiani C, Vaghi F, de Castiglione R.
    Peptides; 1994 Oct 20; 15(4):703-8. PubMed ID: 7937349
    [Abstract] [Full Text] [Related]

  • 13. Characterization of endothelin A (ETA) and endothelin B (ETB) receptors in cultured bovine retinal pericytes.
    McDonald DM, Bailie JR, Archer DB, Chakravarthy U.
    Invest Ophthalmol Vis Sci; 1995 May 20; 36(6):1088-94. PubMed ID: 7730018
    [Abstract] [Full Text] [Related]

  • 14. Ligand binding domain of the human endothelin-B subtype receptor.
    Wada K, Hashido K, Terashima H, Adachi M, Fujii Y, Hiraoka O, Furuichi Y, Miyamoto C.
    Protein Expr Purif; 1995 Jun 20; 6(3):228-36. PubMed ID: 7663155
    [Abstract] [Full Text] [Related]

  • 15. Biological and molecular analyses of structurally reduced analogues of endothelin-1.
    Forget MA, Lebel N, Sirois P, Boulanger Y, Fournier A.
    Mol Pharmacol; 1996 Jun 20; 49(6):1071-9. PubMed ID: 8649345
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endothelin-1 analogues substituted at both position 18 and 19: highly potent endothelin antagonists with no selectivity for either receptor subtype ETA or ETB.
    Kikuchi T, Kubo K, Ohtaki T, Suzuki N, Asami T, Shimamoto N, Wakimasu M, Fujino M.
    J Med Chem; 1993 Dec 10; 36(25):4087-93. PubMed ID: 8258832
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and structure-activity relationship studies of new endothelin pseudopeptide analogues containing alkyl spacers.
    Galoppini C, Giusti L, Macchia M, Hamdan M, Mazzoni MR, Calvani F, Rovero P.
    Farmaco; 1999 Apr 30; 54(4):213-7. PubMed ID: 10384713
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.